899 related articles for article (PubMed ID: 31282586)
1. Xenograft and organoid model systems in cancer research.
Bleijs M; van de Wetering M; Clevers H; Drost J
EMBO J; 2019 Aug; 38(15):e101654. PubMed ID: 31282586
[TBL] [Abstract][Full Text] [Related]
2. Patient-Derived Organoids of Cholangiocarcinoma.
Maier CF; Zhu L; Nanduri LK; Kühn D; Kochall S; Thepkaysone ML; William D; Grützmann K; Klink B; Betge J; Weitz J; Rahbari NN; Reißfelder C; Schölch S
Int J Mol Sci; 2021 Aug; 22(16):. PubMed ID: 34445380
[TBL] [Abstract][Full Text] [Related]
3. Emerging organoid models: leaping forward in cancer research.
Fan H; Demirci U; Chen P
J Hematol Oncol; 2019 Dec; 12(1):142. PubMed ID: 31884964
[TBL] [Abstract][Full Text] [Related]
4. Organoid cultures for the analysis of cancer phenotypes.
Sachs N; Clevers H
Curr Opin Genet Dev; 2014 Feb; 24():68-73. PubMed ID: 24657539
[TBL] [Abstract][Full Text] [Related]
5. A synopsis of prostate organoid methodologies, applications, and limitations.
Gleave AM; Ci X; Lin D; Wang Y
Prostate; 2020 May; 80(6):518-526. PubMed ID: 32084293
[TBL] [Abstract][Full Text] [Related]
6. Applications of patient-derived tumor xenograft models and tumor organoids.
Yoshida GJ
J Hematol Oncol; 2020 Jan; 13(1):4. PubMed ID: 31910904
[TBL] [Abstract][Full Text] [Related]
7. Establishment of a mouse model of pancreatic cancer using human pancreatic cancer cell line S2-013-derived organoid.
Tanaka C; Furihata K; Naganuma S; Ogasawara M; Yoshioka R; Taniguchi H; Furihata M; Taniuchi K
Hum Cell; 2022 Mar; 35(2):735-744. PubMed ID: 35150409
[TBL] [Abstract][Full Text] [Related]
8. Preclinical Modelling of PDA: Is Organoid the New Black?
D'Agosto S; Andreani S; Scarpa A; Corbo V
Int J Mol Sci; 2019 Jun; 20(11):. PubMed ID: 31195689
[TBL] [Abstract][Full Text] [Related]
9. Organoid Culture of Isolated Cells from Patient-derived Tissues with Colorectal Cancer.
Xie BY; Wu AW
Chin Med J (Engl); 2016 Oct; 129(20):2469-2475. PubMed ID: 27748340
[TBL] [Abstract][Full Text] [Related]
10. A novel integrated system using patient-derived glioma cerebral organoids and xenografts for disease modeling and drug screening.
Zhang L; Liu F; Weygant N; Zhang J; Hu P; Qin Z; Yang J; Cheng Q; Fan F; Zeng Y; Tang Y; Li Y; Tang A; He F; Peng J; Liao W; Hu Z; Li M; Liu Z
Cancer Lett; 2021 Mar; 500():87-97. PubMed ID: 33309780
[TBL] [Abstract][Full Text] [Related]
11. Patient-derived lung cancer organoids as in vitro cancer models for therapeutic screening.
Kim M; Mun H; Sung CO; Cho EJ; Jeon HJ; Chun SM; Jung DJ; Shin TH; Jeong GS; Kim DK; Choi EK; Jeong SY; Taylor AM; Jain S; Meyerson M; Jang SJ
Nat Commun; 2019 Sep; 10(1):3991. PubMed ID: 31488816
[TBL] [Abstract][Full Text] [Related]
12. Patient-derived cancer modeling for precision medicine in colorectal cancer: beyond the cancer cell line.
Pyo DH; Hong HK; Lee WY; Cho YB
Cancer Biol Ther; 2020 Jun; 21(6):495-502. PubMed ID: 32208894
[TBL] [Abstract][Full Text] [Related]
13. Organoid Cultures as Preclinical Models of Non-Small Cell Lung Cancer.
Shi R; Radulovich N; Ng C; Liu N; Notsuda H; Cabanero M; Martins-Filho SN; Raghavan V; Li Q; Mer AS; Rosen JC; Li M; Wang YH; Tamblyn L; Pham NA; Haibe-Kains B; Liu G; Moghal N; Tsao MS
Clin Cancer Res; 2020 Mar; 26(5):1162-1174. PubMed ID: 31694835
[TBL] [Abstract][Full Text] [Related]
14. Breast tumour organoids: promising models for the genomic and functional characterisation of breast cancer.
Roelofs C; Hollande F; Redvers R; Anderson RL; Merino D
Biochem Soc Trans; 2019 Feb; 47(1):109-117. PubMed ID: 30626705
[TBL] [Abstract][Full Text] [Related]
15. What role could organoids play in the personalization of cancer treatment?
Francies HE; Garnett MJ
Pharmacogenomics; 2015; 16(14):1523-6. PubMed ID: 26485224
[TBL] [Abstract][Full Text] [Related]
16. Circulating tumor cell-derived organoids: Current challenges and promises in medical research and precision medicine.
Praharaj PP; Bhutia SK; Nagrath S; Bitting RL; Deep G
Biochim Biophys Acta Rev Cancer; 2018 Apr; 1869(2):117-127. PubMed ID: 29360544
[TBL] [Abstract][Full Text] [Related]
17. Organoids: An intermediate modeling platform in precision oncology.
Jin MZ; Han RR; Qiu GZ; Ju XC; Lou G; Jin WL
Cancer Lett; 2018 Feb; 414():174-180. PubMed ID: 29174804
[TBL] [Abstract][Full Text] [Related]
18. Efficient use of patient-derived organoids as a preclinical model for gynecologic tumors.
Maru Y; Tanaka N; Itami M; Hippo Y
Gynecol Oncol; 2019 Jul; 154(1):189-198. PubMed ID: 31101504
[TBL] [Abstract][Full Text] [Related]
19. Preclinical models of pancreatic ductal adenocarcinoma.
Hwang CI; Boj SF; Clevers H; Tuveson DA
J Pathol; 2016 Jan; 238(2):197-204. PubMed ID: 26419819
[TBL] [Abstract][Full Text] [Related]
20. Breakthrough Moments: Organoid Models of Cancer.
Chan AS; Yan HHN; Leung SY
Cell Stem Cell; 2019 Jun; 24(6):839-840. PubMed ID: 31173712
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
